Background: We analysed the impact of clinical study design for oncological pharmaceuticals on the subsequent price … Health Insurance Funds. The analysis was conducted for all oncology pharmaceuticals that underwent the early benefit …. Further analyses should be performed when more oncology pharmaceuticals have passed the early benefit assessment. …

A major producer and exporter of formulated, low-cost generic pharmaceuticals, India increased its exports to major … markets during 2011–17, including sub-Saharan Africa (SSA) and the United States. India is also taking steps to produce more … innovative pharmaceuticals through such measures as accessing U.S. technology through mergers, acquisitions, and licensing, and …

Novartis spent nearly 15 years seeking a patent in India for Glivec. That quest reached its dead end, at last, on April … 1st. India's Supreme Court rejected the Swiss drugmaker's patent. It represents critical issues related to intellectual … pharmaceutical trade in India in the future, as well as India's role as the “Pharmacy of the Developing World”. India's verdict is …

. India ranks third in terms of volume of medicines produced, and is a major global supplier of generic medicines. However …, India depends heavily on the import of several raw materials used to produce some of these medicines. Main Body: This paper … dependence, especially regarding the secure access to essential medicines. India needs a conducive ecosystem to capitalize on the …

tuberculosis drug samples that claim to be made in India and were sold in Africa, India, and five mid-income non-African countries … in India or non-African countries. Since this finding is robust for manufacturer-drug fixed effects, one likely …

current patent regime? In India, health being the main concern would necessarily require more sincere efforts on part of the …